Back to search

Article

Asymmetric dimethylarginine (ADMA) modulates frequency-dependent muscarinic antagonism of β-adrenergic regulation of rat papillary muscle contractility

2026-08-13

Abstract excerpt

<title>Abstract</title> <p>Accumulating evidence implicates the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in cardiovascular impairments. Although the detrimental cardiovascular effects of ADMA have largely been attributed to endothelial dysfunction, recent studies suggest that ADMA also directly affects cardiomyocyte function. However, the action of ADMA on myocardial contracti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
84aaa131-fac1-554b-87d7-736808ad2c33
DOI
10.21203/rs.3.rs-10670314/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Asymmetric dimethylarginine (ADMA) modulates frequency-dependent muscarinic antagonism of β-adrenergic regulation of rat papillary muscle contractilityDOI 10.21203/rs.3.rs-10670314/v1
Select a neighboring publication to make it the new centre.